Table 2.
In-hospital management in patients with fasting glucose <100 mg/dL and ≥ 100 mg/dL
| In-hospital Management | Normal FG (n = 863) | Elevated FG (n = 993) | P value |
|---|---|---|---|
| Reperfusion therapy | 359 (41.6) | 349 (35.1) | 0.004 |
| Thrombolysis | 158 (18.3) | 132 (13.3) | 0.003 |
| Primary PCI | 201 (23.3) | 217 (21.9) | 0.46 |
| Antiplatelets | 847(98.1) | 968 (97.5) | 0.332 |
| Nitrates | 852 (98.7) | 975 (98.2) | 0.351 |
| β-receptor blockers | 610 (70.7) | 664 (66.9) | 0.077 |
| ACEI or ARB | 663 (76.8) | 746 (75.1) | 0.393 |
| Statins | 668 (77.4) | 816 (82.2) | 0.010 |
| Heparins | 787 (91.2) | 900 (90.6) | 0.676 |
PCI percutaneous coronary intervention, ACEI angiotensin-converting-enzyme inhibitor, ARB angiotensin receptor blocker, GIK glucose-insulin-potassium